October 2024

Although patients hope for reduced costs, Pharma’s reaction to the IRA remains to be seen.

Incorporating the teach-back method and providing patient handouts expand health knowledge.

Initiating such discussions can be hard, but they can greatly affect health outcomes.

Had the pharmacy established safe opioid prescribing policies?

With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.

Effectively educating patients about their medications and disease trajectory can improve adherence and outcomes.

New ACIP recommendations provide clarity, but questions linger for those aged 60 to 74 years.

Digital eye strain is a common cause of dry, red, and itchy eyes.

Questions in the pharmacy are endless and often hard to answer.

The updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

Employers can support technicians by investing in certification opportunities.

Criticism and inquiry are coming from all directions. Will investors earn more by holding on to the past or transitioning toward the future?